The Market Reports

Index

1 Nuclear Medicine/Radiopharmaceutic Market Overview
1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceutic
1.2 Nuclear Medicine/Radiopharmaceutic Segment by Type
1.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Other
1.3 Nuclear Medicine/Radiopharmaceutic Segment by Application
1.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Comparison by Application: (2021-2027)
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Global Nuclear Medicine/Radiopharmaceutic Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2016-2027
1.4.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2016-2027
1.4.3 Nuclear Medicine/Radiopharmaceutic Market Size by Region: 2016 Versus 2021 Versus 2027

2 Nuclear Medicine/Radiopharmaceutic Market Competition by Manufacturers
2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers (2016-2021)
2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Nuclear Medicine/Radiopharmaceutic Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Nuclear Medicine/Radiopharmaceutic Manufacturing Sites, Area Served, Product Type
2.5 Nuclear Medicine/Radiopharmaceutic Market Competitive Situation and Trends
2.5.1 Nuclear Medicine/Radiopharmaceutic Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Nuclear Medicine/Radiopharmaceutic Players Market Share by Revenue
2.5.3 Global Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
3.3.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Country
3.3.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
3.4.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Country
3.4.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Region
3.5.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region
3.5.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
3.6.1 Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country
3.6.2 Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
3.7.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country
3.7.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Nuclear Medicine/Radiopharmaceutic Historic Market Analysis by Type
4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2016-2021)
4.3 Global Nuclear Medicine/Radiopharmaceutic Price by Type (2016-2021)

5 Global Nuclear Medicine/Radiopharmaceutic Historic Market Analysis by Application
5.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
5.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2016-2021)
5.3 Global Nuclear Medicine/Radiopharmaceutic Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bracco Imaging
6.2.1 Bracco Imaging Corporation Information
6.2.2 Bracco Imaging Description and Business Overview
6.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.2.5 Bracco Imaging Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Lantheus Medical Imaging
6.4.1 Lantheus Medical Imaging Corporation Information
6.4.2 Lantheus Medical Imaging Description and Business Overview
6.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.4.5 Lantheus Medical Imaging Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Jubilant Pharma
6.6.1 Jubilant Pharma Corporation Information
6.6.2 Jubilant Pharma Description and Business Overview
6.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.6.5 Jubilant Pharma Recent Developments/Updates
6.7 Nordion
6.6.1 Nordion Corporation Information
6.6.2 Nordion Description and Business Overview
6.6.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nordion Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.7.5 Nordion Recent Developments/Updates
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Description and Business Overview
6.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.8.5 Eli Lilly Recent Developments/Updates
6.9 SIEMENS
6.9.1 SIEMENS Corporation Information
6.9.2 SIEMENS Description and Business Overview
6.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.9.5 SIEMENS Recent Developments/Updates
6.10 China Isotope & Radiation
6.10.1 China Isotope & Radiation Corporation Information
6.10.2 China Isotope & Radiation Description and Business Overview
6.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.10.5 China Isotope & Radiation Recent Developments/Updates
6.11 Yantai Dongcheng Biochemicals
6.11.1 Yantai Dongcheng Biochemicals Corporation Information
6.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Description and Business Overview
6.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product Portfolio
6.11.5 Yantai Dongcheng Biochemicals Recent Developments/Updates

7 Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis
7.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
7.4 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nuclear Medicine/Radiopharmaceutic Distributors List
8.3 Nuclear Medicine/Radiopharmaceutic Customers

9 Nuclear Medicine/Radiopharmaceutic Market Dynamics
9.1 Nuclear Medicine/Radiopharmaceutic Industry Trends
9.2 Nuclear Medicine/Radiopharmaceutic Growth Drivers
9.3 Nuclear Medicine/Radiopharmaceutic Market Challenges
9.4 Nuclear Medicine/Radiopharmaceutic Market Restraints

10 Global Market Forecast
10.1 Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nuclear Medicine/Radiopharmaceutic by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceutic by Type (2022-2027)
10.2 Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nuclear Medicine/Radiopharmaceutic by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceutic by Application (2022-2027)
10.3 Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nuclear Medicine/Radiopharmaceutic by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceutic by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Comparison by Application (2021-2027)
Table 3. Global Nuclear Medicine/Radiopharmaceutic Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Nuclear Medicine/Radiopharmaceutic Covered in This Study
Table 5. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) of Key Manufacturers (2016-2021)
Table 6. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Nuclear Medicine/Radiopharmaceutic Average Price (US$/Ton) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Nuclear Medicine/Radiopharmaceutic Manufacturing Sites and Area Served
Table 11. Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nuclear Medicine/Radiopharmaceutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceutic as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Nuclear Medicine/Radiopharmaceutic Sales by Region (2016-2021) & (Kiloton)
Table 16. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2016-2021)
Table 17. Global Nuclear Medicine/Radiopharmaceutic Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021) & (Kiloton)
Table 19. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2016-2021)
Table 20. North America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2016-2021)
Table 22. Europe Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021) & (Kiloton)
Table 23. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2016-2021)
Table 24. Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region (2016-2021) & (Kiloton)
Table 27. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2016-2021)
Table 30. Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021) & (Kiloton)
Table 31. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2016-2021)
Table 32. Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021) & (Kiloton)
Table 35. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2016-2021)
Table 38. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2016-2021)
Table 39. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
Table 40. Global Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) by Type (2016-2021)
Table 41. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2016-2021)
Table 42. Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Type (2016-2021)
Table 43. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2016-2021)
Table 44. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
Table 45. Global Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) by Application (2016-2021)
Table 46. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Application (2016-2021)
Table 47. Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Application (2016-2021)
Table 48. GE Healthcare Corporation Information
Table 49. GE Healthcare Description and Business Overview
Table 50. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 51. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product
Table 52. GE Healthcare Recent Developments/Updates
Table 53. Bracco Imaging Corporation Information
Table 54. Bracco Imaging Description and Business Overview
Table 55. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 56. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product
Table 57. Bracco Imaging Recent Developments/Updates
Table 58. Mallinckrodt Corporation Information
Table 59. Mallinckrodt Description and Business Overview
Table 60. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 61. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product
Table 62. Mallinckrodt Recent Developments/Updates
Table 63. Lantheus Medical Imaging Corporation Information
Table 64. Lantheus Medical Imaging Description and Business Overview
Table 65. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 66. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product
Table 67. Lantheus Medical Imaging Recent Developments/Updates
Table 68. Bayer Corporation Information
Table 69. Bayer Description and Business Overview
Table 70. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 71. Bayer Nuclear Medicine/Radiopharmaceutic Product
Table 72. Bayer Recent Developments/Updates
Table 73. Jubilant Pharma Corporation Information
Table 74. Jubilant Pharma Description and Business Overview
Table 75. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 76. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product
Table 77. Jubilant Pharma Recent Developments/Updates
Table 78. Nordion Corporation Information
Table 79. Nordion Description and Business Overview
Table 80. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 81. Nordion Nuclear Medicine/Radiopharmaceutic Product
Table 82. Nordion Recent Developments/Updates
Table 83. Eli Lilly Corporation Information
Table 84. Eli Lilly Description and Business Overview
Table 85. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 86. Eli Lilly Nuclear Medicine/Radiopharmaceutic Product
Table 87. Eli Lilly Recent Developments/Updates
Table 88. SIEMENS Corporation Information
Table 89. SIEMENS Description and Business Overview
Table 90. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 91. SIEMENS Nuclear Medicine/Radiopharmaceutic Product
Table 92. SIEMENS Recent Developments/Updates
Table 93. China Isotope & Radiation Corporation Information
Table 94. China Isotope & Radiation Description and Business Overview
Table 95. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 96. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product
Table 97. China Isotope & Radiation Recent Developments/Updates
Table 98. Yantai Dongcheng Biochemicals Corporation Information
Table 99. Yantai Dongcheng Biochemicals Description and Business Overview
Table 100. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 101. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product
Table 102. Yantai Dongcheng Biochemicals Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Nuclear Medicine/Radiopharmaceutic Distributors List
Table 106. Nuclear Medicine/Radiopharmaceutic Customers List
Table 107. Nuclear Medicine/Radiopharmaceutic Market Trends
Table 108. Nuclear Medicine/Radiopharmaceutic Growth Drivers
Table 109. Nuclear Medicine/Radiopharmaceutic Market Challenges
Table 110. Nuclear Medicine/Radiopharmaceutic Market Restraints
Table 111. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2022-2027) & (Kiloton)
Table 112. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Type (2022-2027)
Table 113. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 114. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Type (2022-2027)
Table 115. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2022-2027) & (Kiloton)
Table 116. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Application (2022-2027)
Table 117. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 118. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Application (2022-2027)
Table 119. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Region (2022-2027) & (Kiloton)
Table 120. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Region (2022-2027)
Table 121. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 122. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Region (2022-2027)
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nuclear Medicine/Radiopharmaceutic
Figure 2. Global Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2020 & 2027
Figure 3. Tc-99 Product Picture
Figure 4. I-123/131 Product Picture
Figure 5. In-111 Product Picture
Figure 6. Xe-133 Product Picture
Figure 7. Th-201 Product Picture
Figure 8. Ga-67 Product Picture
Figure 9. Other Product Picture
Figure 10. Global Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2020 & 2027
Figure 11. Diagnostic
Figure 12. Therapeutic
Figure 13. Global Nuclear Medicine/Radiopharmaceutic Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nuclear Medicine/Radiopharmaceutic Market Size 2016-2027 (US$ Million)
Figure 15. Global Nuclear Medicine/Radiopharmaceutic Sales 2016-2027 (Kiloton)
Figure 16. Global Nuclear Medicine/Radiopharmaceutic Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers in 2020
Figure 18. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Nuclear Medicine/Radiopharmaceutic Players: Market Share by Revenue in 2020
Figure 20. Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2016-2021)
Figure 22. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2020
Figure 23. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2016-2021)
Figure 24. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2020
Figure 25. U.S. Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2016-2021)
Figure 50. Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application (2016-2021)
Figure 51. Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application in 2020
Figure 52. Revenue Share of Nuclear Medicine/Radiopharmaceutic by Application (2016-2021)
Figure 53. Revenue Share of Nuclear Medicine/Radiopharmaceutic by Application in 2020
Figure 54. Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Figure 55. Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
Figure 56. Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed